FDA-Inspected Site

Janssen Biotech Inc.

7 FDA inspections are on record for Janssen Biotech Inc. in Horsham, United States.

Clean· No action indicated

Horsham, United States · Last updated July 10, 2026

Overview

  • 7 FDA inspections are on record.
  • 3 inspections produced a Form 483.
  • The most recent recorded inspection date is 2025-01-17.

At a glance

Inspections

7

Form 483s

3

EIRs

1

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
13 Jan 2025 – 17 Jan 2025Human DrugsClean
16 Sep 2024 – 24 Sep 2024Human DrugsClean
18 Jun 2018 – 22 Jun 2018Human DrugsClean
4 Feb 2016 – 25 Feb 2016Human Drugs483View 483 →
19 Nov 2015 – 24 Nov 2015Human DrugsClean
14 Apr 2011Not recorded483View 483 →
2 Oct 2009Not recorded483On file

Observations on record

Form 483 observations cited at this site, most recent first.

25 Feb 2016
21 CFR 314.80(b)

Failure to develop written procedures

Cited by Craig D Zagata, Matthew R Noonan

25 Feb 2016
21 CFR 211.198(a)

Complaint Handling Procedure

Cited by Craig D Zagata, Matthew R Noonan

25 Feb 2016
21 CFR 211.198(a)

Complaint Handling Procedure

Cited by Craig D Zagata, Matthew R Noonan

25 Feb 2016
21 CFR 314.80(b)

Failure to develop written procedures

Cited by Craig D Zagata, Matthew R Noonan

14 Apr 2011
21 CFR 211.198(a)

Complaint Handling Procedure

Cited by Joseph L Despins

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.198(a)Cited across public-safe Form 483 observations3x
21 CFR 314.80(b)Cited across public-safe Form 483 observations2x

Full site report

Get the verbatim findings behind Janssen Biotech Inc.'s 3 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat